Literature DB >> 11757969

Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.

R Geisel1, F J Schmitz, A C Fluit, H Labischinski.   

Abstract

In order to understand the mechanism(s) of the resistance/reduced susceptibility of Staphylococcus aureus to glycopeptide antibiotics, the current data on the modes of action of glycopeptides were reviewed. In addition, the different test systems for detecting vancomycin resistance and the clinical relevance of resistant Staphylococcus aureus were analyzed. Finally, strategies to prevent the nosocomial spread of these bacteria are presented, as are new therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757969     DOI: 10.1007/s100960100595

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.

Authors:  Susan Boyle-Vavra; Shaohui Yin; Mamatha Challapalli; Robert S Daum
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals.

Authors:  Julien Haroche; Anne Morvan; Marilyne Davi; Jeanine Allignet; François Bimet; Névine El Solh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Christine Barras; Patrice François; Yvan Charbonnier; Elzbieta Huggler; Christian Garzoni; William L Kelley; Paul Majcherczyk; Jacques Schrenzel; Daniel P Lew; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Asllan Gjinovci; Manuela Bento; Dongmei Li; Jacques Schrenzel; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

Authors:  Peter Sass; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

6.  In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

Authors:  N McCallum; H Karauzum; R Getzmann; M Bischoff; P Majcherczyk; B Berger-Bächi; R Landmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.

Authors:  George Sakoulas; Jeff Alder; Claudie Thauvin-Eliopoulos; Robert C Moellering; George M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Patrice Francois; Dongmei Li; William L Kelley; Daniel P Lew; Pierre Vaudaux; Jacques Schrenzel
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  Chia-Yu Chi; Tsai-Ling Lauderdale; Shih-Min Wang; Jing-Ming Wu; Yu-Jen Yang; Ching-Chuan Liu
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

10.  Oritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureus.

Authors:  Sung Joon Kim; Manmilan Singh; Jacob Schaefer
Journal:  J Mol Biol       Date:  2009-06-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.